Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TCR2 Therapeutics Inc.

    NASDAQ: TCRR · Real-Time Price · USD
    1.48
    0.00 (0.00%)
    At close: May 31, 2023, 10:00 PM

    TCR2 Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -153.5M -99.74M
    Interest Income
    		 1.94M 224K
    Pretax Income
    		 -151.56M -99.52M
    Net Income
    		 -151.82M -99.81M
    Selling & General & Admin
    		 24.44M 22.5M
    Research & Development
    		 98.64M 77.24M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 123.08M 99.74M
    Interest Expense
    		 58.9M n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 123.08M 99.74M
    Income Tax Expense
    		 261K 289K
    Shares Outstanding (Basic)
    		 38.63M 37.94M
    Shares Outstanding (Diluted)
    		 38.63M 37.94M
    EPS (Basic)
    		 -3.93 -2.63
    EPS (Diluted)
    		 -3.93 -2.63
    EBITDA
    		 -89.62M -96.92M
    EBIT
    		 -92.67M -99.74M
    Depreciation & Amortization
    		 63.88M 2.83M

    Add to Watchlist